“Patents on semaglutide will soon expire in many countries, including India, China, Brazil, Turkey, Canada, and South Africa, permitting cheaper generic versions of the weight loss drug in countries home to a large share of the world’s overweight population,” reports The Doomslayer.
Read Full Article: https://libertyunyielding.com/2026/03/24/anti-obesity-drugs-will-get-much-cheaper-in-many-countries/
